Lisa Bright

Director/Board Member at ASCENDIS PHARMA A/S

Net worth: - $ as of 2026-05-30

59 year

72 connections

Health Technology

Finance

Commercial Services

Profile

Lisa Jane Bright is currently Chairman at Metadeq, Inc., Non-Executive Director at Dechra Pharmaceuticals Ltd. since 2019, Independent Director at Ascendis Pharma A since 2017, Director at Immedica Pharma AB, Advisor at DRI Healthcare, Executive Partner at Syncona Partners LLP, and President-International at Intercept Pharma Europe Ltd. since 2016.
Former roles include Chairman at Resolution Therapeutics Ltd., Vice President at Gilead Sciences, Inc., President-International at Intercept Pharmaceuticals, Inc. from 2016 to 2021, VP-Commercial Planning & Operations at GSK Plc from 1989 to 2006, General Manager at Gilead Sciences Ireland UC from 2008 to 2014, General Manager- UK & Ireland at Gilead Sciences Ltd. from 2008 to 2014, and Executive Partner at Syncona Ltd. Education includes undergraduate studies at University College London.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ASCENDIS PHARMA A/S -.--%	2025-12-30	0 ( -.--% )	- $	2026-05-30

Lisa Bright active positions

Companies	Position	Start
ASCENDIS PHARMA A/S	Director/Board Member	2017-03-31
DECHRA PHARMACEUTICALS	Director/Board Member	2019-01-31
Intercept Pharma Europe Ltd. Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and sells pharmaceutical products	Corporate Officer/Principal	2016-06-30
DRI Healthcare DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors.	Consultant / Advisor	-
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Consultant / Advisor	-
Immedica Pharma AB Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care	Director/Board Member	-

All active positions of Lisa Bright

Former positions of Lisa Bright

Companies	Position	End
Resolution Therapeutics Ltd. Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in biotechnology	Chairman	2024-10-02
INTERCEPT PHARMACEUTICALS, INC.	Corporate Officer/Principal	2020-12-31
Gilead Sciences Ireland UC Gilead Sciences Ireland UC Pharmaceuticals: MajorHealth Technology Engages in discover, develops and deliver innovative therapeutics for life-threatening diseases	Corporate Officer/Principal	2014-10-31
░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Lisa Bright's experience

Training of Lisa Bright

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lisa Bright's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Gilead Sciences, Inc. Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases	Health Technology
DRI Healthcare DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors.	Finance
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases	Health Technology
Syncona Ltd. Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust	Miscellaneous
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
Dechra Pharmaceuticals Ltd. Dechra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells veterinary pharmaceuticals	Health Technology
University College London University College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ascendis Pharma A/S Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology	Health Technology
Immedica Pharma AB Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops medicines for rare, genetic and metabolic diseases, hematology & oncology and specialty care	Health Technology
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Finance
Gilead Sciences Ireland UC Gilead Sciences Ireland UC Pharmaceuticals: MajorHealth Technology Engages in discover, develops and deliver innovative therapeutics for life-threatening diseases	Health Technology
Gilead Sciences Ltd. Gilead Sciences Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products	Distribution Services
Intercept Pharma Europe Ltd. Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and sells pharmaceutical products	Commercial Services
Resolution Therapeutics Ltd. Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development in biotechnology	Commercial Services